SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hanna Vasarainen, Hanna Malmi, Liisa Määttänen, Mirja Ruutu, Teuvo Tammela, Kimmo Taari, Antti Rannikko, Anssi Auvinen, Effects of prostate cancer screening on health-related quality of life: Results of the Finnish arm of the European randomized screening trial (ERSPC), Acta Oncologica, 2013, 52, 8, 1615

    CrossRef

  2. 2
    Grace Hui-Min Wu, Anssi Auvinen, Amy Ming-Fang Yen, Matti Hakama, Stephen D. Walter, Hsiu-Hsi Chen, A stochastic model for survival of early prostate cancer with adjustments for leadtime, length bias, and over-detection, Biometrical Journal, 2012, 54, 1
  3. 3
    Grace Hui-Min Wu, Anssi Auvinen, Liisa Määttänen, Teuvo L.J. Tammela, Ulf-Håkan Stenman, Matti Hakama, Amy Ming-Fang Yen, Hsiu-Hsi Chen, Number of screens for overdetection as an indicator of absolute risk of overdiagnosis in prostate cancer screening, International Journal of Cancer, 2012, 131, 6
  4. 4
    Meelan Bul, Roderick C. N. van den Bergh, Xiaoye Zhu, Antti Rannikko, Hanna Vasarainen, Chris H. Bangma, Fritz H. Schröder, Monique J. Roobol, Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer, BJU International, 2012, 110, 11
  5. 5
    Stacy Loeb, Sigrid Carlsson, R. Scott Braithwaite, Prostate cancer: Modeling the outcomes of prostate cancer screening, Nature Reviews Urology, 2012, 9, 4, 183

    CrossRef

  6. 6
    Grace Hui-Min Wu, Anssi Auvinen, Amy Ming-Fang Yen, Matti Hakama, Teuvo L. Tammela, Ulf-Håkan Stenman, Paula Kujala, Mirja Ruutu, Hsiu-Hsi Chen, The Impact of Interscreening Interval and Age on Prostate Cancer Screening With Prostate-Specific Antigen, European Urology, 2012, 61, 5, 1011

    CrossRef

  7. 7
    Pim J. van Leeuwen, David Connolly, Teuvo L. J. Tammela, Anssi Auvinen, Ries Kranse, Monique J. Roobol, Fritz H. Schroder, Anna Gavin, Balancing the harms and benefits of early detection of prostate cancer, Cancer, 2010, 116, 20
  8. 8
    Teemu J. Murtola, Teuvo L.J. Tammela, Liisa Määttänen, Heini Huhtala, Elizabeth A. Platz, Martti Ala-Opas, Ulf-Håkan Stenman, Anssi Auvinen, Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial, International Journal of Cancer, 2010, 127, 7
  9. 9
    P J van Leeuwen, H A van Vugt, C H Bangma, The implementation of screening for prostate cancer, Prostate Cancer and Prostatic Diseases, 2010, 13, 3, 218

    CrossRef

  10. 10
    Hanna Malmi, Mirja Ruutu, Liisa Määttänen, Ulf-Håkan Stenman, Harri Juusela, Teuvo L.J. Tammela, Anssi Auvinen, Why do men opt out of prostate-cancer screening? Attitudes and perception among participants and non-participants of a screening trial, BJU International, 2010, 106, 4
  11. 11
    Roderick C.N. Van Den Bergh, Stijn Roemeling, Monique J. Roobol, Gunnar Aus, Jonas Hugosson, Antti S. Rannikko, Teuvo L. Tammela, Chris H. Bangma, Fritz H. Schröder, Gleason score 7 screen-detected prostate cancers initially managed expectantly: outcomes in 50 men, BJU International, 2009, 103, 11
  12. 12
    Roderick C.N. van den Bergh, Stijn Roemeling, Monique J. Roobol, Gunnar Aus, Jonas Hugosson, Antti S. Rannikko, Teuvo L. Tammela, Chris H. Bangma, Fritz H. Schröder, Outcomes of Men with Screen-Detected Prostate Cancer Eligible for Active Surveillance Who Were Managed Expectantly, European Urology, 2009, 55, 1, 1

    CrossRef

  13. 13
    Patrik Finne, Anssi Auvinen, Liisa Määttänen, Teuvo L. Tammela, Mirja Ruutu, Harri Juusela, Paula Martikainen, Matti Hakama, Ulf-Håkan Stenman, Diagnostic Value of Free Prostate-Specific Antigen among Men with a Prostate-Specific Antigen Level of <3.0μg per Liter, European Urology, 2008, 54, 2, 362

    CrossRef

  14. 14
    Fritz H. Schröder, Screening for prostate cancer (PC)—an update on recent findings of the European Randomized Study of Screening for Prostate Cancer (ERSPC), Urologic Oncology: Seminars and Original Investigations, 2008, 26, 5, 533

    CrossRef